Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated otherwise.
August 21, 2025
by PRNewswire
Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies
Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash.
August 2, 2025
by ACN Newswire
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases
The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy.
July 9, 2024
by Biotech Newswire
Which pharmaceutical giant is most willing to invest, and which excels at generating profits?
The significance of R&D investment in biopharmaceutical companies cannot be overstated.
May 27, 2024
by Krebs Qin
InnoCare Appoints Xin Fu as Chief Financial Officer
InnoCare Pharma, announced today that the Company appointed Mr. Xin Fu, who has extensive finance-related experience, as the Chief Financial Officer.
December 18, 2023
by PharmaSources
4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection
In a significant financial milestone, Xlife Sciences AG invests CHF 23.3 million in 4D Lifetec AG, acquiring a 20% stake in the company.
November 6, 2023
by B3C newswire
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
Avantor announced it will create a new manufacturing and distribution Hub in Singapore.
May 5, 2022
by PharmaSources.com
2021 — the year UK biotechs broke investment records
Initial Public Offerings totalled £1,304 million, an increase of 434% from 2020, but more needs to be done to connect the UK's life sciences and finance sectors.
February 10, 2022
by CPhIonline
Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction
Coller Capital and Ping An Overseas Holdings together with its subsidiaries, the main offshore investment and asset management platform of Ping An Insurance (Group) Company of China, Ltd., have closed one of the world's largest private credit ...
August 4, 2021
by prnasia
Sanofi invests 50 million euros in Jeito Capital
The investment will be deployed by Jeito’s team, in line with its investment criteria, to support French and European healthcare entrepreneurs.
November 16, 2020
by expresspharma
Recipharm Invests €2.6M in Kaysersberg Facility
The Kaysersberg facility specializes in producing sterile liquids for therapeutic areas including eye care and ear drops.
October 16, 2020
by contractpharma
UK biotech companies raise over £1bn in record quarter
In new data published by the BioIndustry Association (BIA) and Clarivate, UK biotech companies reportedly raised over £1bn in equity finance between June and August 2020.
October 15, 2020
by pharmatimes